development of broad spectrum insecticides using a rational design approach
DESCRIPTION
Development of Broad Spectrum Insecticides Using a Rational Design Approach And Vector Genomic Data. Photos Courtesy of Tim Gathany, CDC Photoservices. Pipeline. Target Identification • Genome Mining • Selection of genes with high “therapeutic index” (TI). ~ 150 gene models. - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Development of Broad Spectrum Insecticides Using a Rational Design Approach](https://reader035.vdocument.in/reader035/viewer/2022081520/56816679550346895dda17a8/html5/thumbnails/1.jpg)
Development of Broad Spectrum Insecticides Using a Rational Design Approach
And Vector Genomic Data
Photos Courtesy of Tim Gathany, CDC Photoservices
![Page 2: Development of Broad Spectrum Insecticides Using a Rational Design Approach](https://reader035.vdocument.in/reader035/viewer/2022081520/56816679550346895dda17a8/html5/thumbnails/2.jpg)
~ 150 gene models
~ 5-10 genes
~ 5 genes
2-4 genesPrimary Screen• Assay Development• Preliminary Screening (~1-5K compounds)• Identification of “lead chemistries”
Target Validation• Gene Expression Profiling• Analysis of knock-down phenotype• Cell-based assays
Future Work• High-throughput screening (~100-300K
compounds)• In Silico Screening• Novel Vector Genome Sequencing
Target Identification • Genome Mining • Selection of genes with high “therapeutic index”
(TI)
1-3 prioritized targets
Pipeline
![Page 3: Development of Broad Spectrum Insecticides Using a Rational Design Approach](https://reader035.vdocument.in/reader035/viewer/2022081520/56816679550346895dda17a8/html5/thumbnails/3.jpg)
Target IdentificationGenome
Mining • Vector Genomes
Anopheles gambaieAedes aegyptiCulex pipiensIxodes scapularisPhelbotomus papatasiLutzomyia longipalpis
• High Priority Targets (Druggable)
G protein-coupled receptors (GPCRs)Ion Channels
• Multi-gene Family• Essential Functions• Highly Specific
![Page 4: Development of Broad Spectrum Insecticides Using a Rational Design Approach](https://reader035.vdocument.in/reader035/viewer/2022081520/56816679550346895dda17a8/html5/thumbnails/4.jpg)
GaGb
GgGDPGTP
Adenylyl CyclaseATP
cAMP
GPCRs• ~27% Current Drugs target
GPCRs• Amenable to Screening
Ca++
![Page 5: Development of Broad Spectrum Insecticides Using a Rational Design Approach](https://reader035.vdocument.in/reader035/viewer/2022081520/56816679550346895dda17a8/html5/thumbnails/5.jpg)
Ion Channels• Current Insecticide Targets
• Voltage Gated/Ligand Gated• Multi-Component/Multi-Protein• High-throughput
Electrophysiology
![Page 6: Development of Broad Spectrum Insecticides Using a Rational Design Approach](https://reader035.vdocument.in/reader035/viewer/2022081520/56816679550346895dda17a8/html5/thumbnails/6.jpg)
Target IdentificationGenome
Mining • Vector Genomes
Anopheles gambaieAedes aegyptiCulex pipiensIxodes scapularisPhelbotomus papatasiLutzomyia longipalpis
• High Priority Targets (Drugable)G protein-coupled receptors (GPCRs)Ion Channels
• BioinformaticsBlast-based Homology SearchesExisting Algorithms (QFC)Novel Algorithms Computational Modeling
Selection of Genes with High “Therapeutic Index”
![Page 7: Development of Broad Spectrum Insecticides Using a Rational Design Approach](https://reader035.vdocument.in/reader035/viewer/2022081520/56816679550346895dda17a8/html5/thumbnails/7.jpg)
~ 150 gene models
~ 5-10 genes
~ 5 genes
2-4 genesPrimary Screen• Assay Development• Preliminary Screening (~1-5K compounds)• Identification of “lead chemistries”
Target Validation• Gene Expression Profiling• Analysis of knock-down phenotype• Cell-based assays
Future Work• High-throughput screening (~100-300K
compounds)• In Silico Screening• Novel Vector Genome Sequencing
Target Identification • Genome Mining • Selection of genes with high “therapeutic index”
(TI)
1-3 prioritized targets
Pipeline
![Page 8: Development of Broad Spectrum Insecticides Using a Rational Design Approach](https://reader035.vdocument.in/reader035/viewer/2022081520/56816679550346895dda17a8/html5/thumbnails/8.jpg)
Target ValidationGene Expression Profiling (RT-
PCR) • Vector Species
Broad Spectrum Vector Specific
• Developmental Stages Adult
• Tissue Expression
Synganglion
“Loss of Function” Screening • RNAi – knock down
Adults (Cell lines) Lethal Effect or Paralysis
• FlyRNAi DatabaseLethal Phenotypes
“Gain of Function”
????
Cell-based Assays
• Expression• Functional
![Page 9: Development of Broad Spectrum Insecticides Using a Rational Design Approach](https://reader035.vdocument.in/reader035/viewer/2022081520/56816679550346895dda17a8/html5/thumbnails/9.jpg)
~ 150 gene models
~ 5-10 genes
~ 5 genes
2-4 genesPrimary Screen• Assay Development• Preliminary Screening (~1-5K compounds)• Identification of “lead chemistries”
Target Validation• Gene Expression Profiling• Analysis of knock-down phenotype• Cell-based assays
Future Work• High-throughput screening (~100-300K
compounds)• In Silico Screening• Novel Vector Genome Sequencing
Target Identification • Genome Mining • Selection of genes with high “therapeutic index”
(TI)
1-3 prioritized targets
Pipeline
![Page 10: Development of Broad Spectrum Insecticides Using a Rational Design Approach](https://reader035.vdocument.in/reader035/viewer/2022081520/56816679550346895dda17a8/html5/thumbnails/10.jpg)
Primary ScreenHeterologous Expression
Systems • Traditional Cloning/synthesis
• Mammalian, Insect, Yeast• Commericial & “Home Grown” vectors• Ca2+/cAMP
Libraries • LOPAC1280
• TimTec• Maybridge• Notre Dame-Miller Group• Industry
![Page 11: Development of Broad Spectrum Insecticides Using a Rational Design Approach](https://reader035.vdocument.in/reader035/viewer/2022081520/56816679550346895dda17a8/html5/thumbnails/11.jpg)
~ 150 gene models
~ 5-10 genes
~ 5 genes
2-4 genesPrimary Screen• Assay Development• Preliminary Screening (~1-5K compounds)• Identification of “lead chemistries”
Target Validation• Gene Expression Profiling• Analysis of knock-down phenotype• Cell-based assays
Future Work• High-throughput screening (~100-300K
compounds)• In Silico Screening• Novel Vector Genome Sequencing
Target Identification • Genome Mining • Selection of genes with high “therapeutic index”
(TI)
1-3 prioritized targets
Pipeline
![Page 12: Development of Broad Spectrum Insecticides Using a Rational Design Approach](https://reader035.vdocument.in/reader035/viewer/2022081520/56816679550346895dda17a8/html5/thumbnails/12.jpg)
Prioritizing Targets:Tier 1 & Tier 2 Arthropod GPCRs
GPCR Receptor
Family
Predicted Receptor
Class
Name/Number Receptors Identified in GenomeAnopheles gambiae1
Aedes aegypti2 Ixodes scapularis3
Tier 1 – Immediate ScreeningDopamine Biogenic
Aminedop1, dop2, dop3 dop1, dop2, dop3 dop1, dop2, dop3
Muscarinic acetylcholine
“ “ mAcR1, mAcR2, mAcR3
mAcR1, mAcR2, mAcR3
mAcR1, mAcR2, mAcR3
Octopamine “ “ oar1, oar2, oar3, oar4
oar1, oar2, oar3, oar4
oar1, oar2, oar3, oar4
Serotonin “ “ 5ht1, 5ht2, 5ht3, 5ht4, 5ht5
5ht1, 5ht2, 5ht3, 5ht4, 5ht5
5ht1, 5ht2, 5ht3, 5ht4, 5ht5
Tier 2 – Functional AnalysisHistamine Biogenic
aminehis1 his1 his1
Calcitonin Peptide cal1, cal2, cal3 cal1, cal2, cal3 cal1, cal2, cal3
SIFamide “ “ sif1, sif2 sif1, sif2 sif1, sif2Opioid “ “ opr1 opr1 opr1Metabotropic glutamate
Amino acid mgl1, mgl2, mgl3, mgl4,mgl5
mgl1, mgl2, mgl3, mgl4, mgl5
mgl1, mgl2, mgl3, mgl4, mgl5
GABAB “ “ gbb1, gbb2, gbb3 gbb1, gbb2, gbb3 gbb1, gbb2, gbb3Latrophilin Neurotoxin cir1 cir1 cir1
[1. Hill et al., 2002; 2. Nene et al., 2007; 3. Hill et al., unpublished]
![Page 13: Development of Broad Spectrum Insecticides Using a Rational Design Approach](https://reader035.vdocument.in/reader035/viewer/2022081520/56816679550346895dda17a8/html5/thumbnails/13.jpg)
Exon 1 (315 bp) Exon 2 (129 bp) Exon 3 (258 bp) Exon 4 (537 bp)36628 bp 133823 bp 86933 bp
EST
Exon 1 (1255 bp) Exon 2 (84 bp) Exon 3 ( 71 bp)54361 bp 482 bp 86303 bp
EST
Contig 1 Contig 2
EST
1552 bp37873 bp
18033 bp 13023 bp 118 bpExon 1 (109 bp) Exon 2 (252 bp) Exon 3 (223 bp) Exon 4 (86 bp) Exon 5 (200 bp) Exon 6 (143 bp) Exon 8 (211 bp)Exon 7 (108 bp)
Intron30527 bp
Putative first exon, found using two 7TM regions from trace file
GPRd
op1
GPRd
op3
Identification of Aedes Dopamine Receptors
Initiation methionine Stop codon 7TM region
GPRd
op2
![Page 14: Development of Broad Spectrum Insecticides Using a Rational Design Approach](https://reader035.vdocument.in/reader035/viewer/2022081520/56816679550346895dda17a8/html5/thumbnails/14.jpg)
Dop1 Dop2 Dop3
2kb
1kb
0.3kb
Detection of Aedes GPRdop transcripts
splice variants
Target Validation
• Jason Meyer
• Cate Hill
![Page 15: Development of Broad Spectrum Insecticides Using a Rational Design Approach](https://reader035.vdocument.in/reader035/viewer/2022081520/56816679550346895dda17a8/html5/thumbnails/15.jpg)
Acknowledgements
Cate Hill Charles Buck
Val WattsLarisa
Avramova
Ed RowtonDept. of
Entomology
Mary Ann McDowell
Frank CollinsJesus IsaguirreScott EmrichMarv Miller
FundingIndiana 21C Res. Technol.
FundPurdue Disc. Park Seed
GrantTATRC/DoD
Nialah Orr
Special ThanksGabriella ZollnerKendra Lawrence
Russ Coleman
![Page 16: Development of Broad Spectrum Insecticides Using a Rational Design Approach](https://reader035.vdocument.in/reader035/viewer/2022081520/56816679550346895dda17a8/html5/thumbnails/16.jpg)
Aim 2: Target Validation (Developing Strength)
RT-PCR• Confirm annotation & transcripts (tissues/stages)• Guide cloning efforts• HTP proteomics?
RNAi• Only approach to investigate phenotype• Many limitations
Biochemical Assay
Dop1 Dop2 Dop3
2kb
1kb
0.3kb
Detection of Aedes GPRdop transcripts
splice variants
F, forskolin; D, dopamine; S, serotonin; O, octopamine; T, tyramine